28 October 2021 - The White House is abandoning every single policy idea aimed at lowering prescription drug prices in President Biden’s domestic spending package, it announced Thursday morning.
Biden is effectively admitting he can’t overcome deeply entrenched pharmaceutical industry opposition to any change to the status quo, even with broad political support for the effort, and both chambers of Congress in Democratic control.